| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 3.212 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 3.212 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 8.727 | 1.048 | 617 | 991 | 1.385 | 1.720 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | -5.516 | -1.048 | -617 | -991 | -1.385 | -1.720 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | -5.612 | -1.048 | -617 | -991 | -1.385 | -1.720 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Prodromagra Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.898 | 2.869 | 2.820 | 2.768 | 2.677 | 2.520 | 2.369 | 2.271 | 2.167 | 2.049 |
| Current Assets | 5.730 | 5.671 | 5.575 | 5.473 | 34 | 38 | 0 | 0 | 26 | 0 |
| Inventories | 5.556 | 5.499 | 5.406 | 5.307 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 45 | 45 | 44 | 43 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 129 | 127 | 125 | 123 | 34 | 38 | 0 | 0 | 26 | 0 |
| Shareholders Funds | -530 | -525 | -516 | -507 | 1.690 | 610 | -21 | -1.012 | -2.394 | -4.101 |
| Social Capital | 203 | 201 | 198 | 194 | 148 | 146 | 142 | 143 | 142 | 142 |
| Debts | 9.158 | 9.065 | 8.911 | 8.748 | 1.021 | 1.948 | 2.390 | 3.284 | 4.588 | 6.149 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Prodromagra Srl